Pharma Industry- Uk
STRATEGIC GROUP THEORY: REVIEW, EXAMINATION AND APPLICATION IN THE UK PHARMACEUTICAL INDUSTRY
by Graham Leask & David Parker
Graham Leask, Aston Business School, Aston University, Birmingham B4 7ET, UK and David Parker, Cranfield School of Management, Cranfield University, Bedfordshire MK43 0AL, UK
ACKNOWLEDGMENT The authors would like to acknowledge the valuable assistance of IMS Health in the preparation of this manuscript, in particular the assistance of Alan Johnson, and the helpful comments of a referee on an earlier draft of the paper.
Strategic Group Theory: review, examination and application in the UK pharmaceutical industry.
Strategic Group Theory: review, examination and application in the UK pharmaceutical industry. Structured Abstract Category Keywords: General review. strategic groups, strategic mapping, industrial structure, UK, pharmaceutical industry.
Purpose of this This paper considers the current status of strategic group theory in the light paper of developments over the last three decades. It then goes on to discuss the continuing value of the concept, both to strategic management research and practising managers. Methodology Critical review of the idea of strategic groups together with a practical strategic mapping illustration. Findings Strategic group theory still provides a useful approach for management research, which allows a detailed appraisal and comparison of company strategies within an industry. Research implications Strategic group research would undoubtedly benefit from more directly comparable, industry-specific studies, with a more careful focus on variable selection and the statistical methods used for validation. Future studies should aim to build sets of industry specific variables that describe strategic choice within that industry. The statistical methods used to identify strategic groupings need to be robust to ensure that strategic groups are not solely an artefact of method. Practical implications The
by Graham Leask & David Parker
Graham Leask, Aston Business School, Aston University, Birmingham B4 7ET, UK and David Parker, Cranfield School of Management, Cranfield University, Bedfordshire MK43 0AL, UK
ACKNOWLEDGMENT The authors would like to acknowledge the valuable assistance of IMS Health in the preparation of this manuscript, in particular the assistance of Alan Johnson, and the helpful comments of a referee on an earlier draft of the paper.
Strategic Group Theory: review, examination and application in the UK pharmaceutical industry.
Strategic Group Theory: review, examination and application in the UK pharmaceutical industry. Structured Abstract Category Keywords: General review. strategic groups, strategic mapping, industrial structure, UK, pharmaceutical industry.
Purpose of this This paper considers the current status of strategic group theory in the light paper of developments over the last three decades. It then goes on to discuss the continuing value of the concept, both to strategic management research and practising managers. Methodology Critical review of the idea of strategic groups together with a practical strategic mapping illustration. Findings Strategic group theory still provides a useful approach for management research, which allows a detailed appraisal and comparison of company strategies within an industry. Research implications Strategic group research would undoubtedly benefit from more directly comparable, industry-specific studies, with a more careful focus on variable selection and the statistical methods used for validation. Future studies should aim to build sets of industry specific variables that describe strategic choice within that industry. The statistical methods used to identify strategic groupings need to be robust to ensure that strategic groups are not solely an artefact of method. Practical implications The
References: Agrawal, M. (1999) Global Competitiveness in the Pharmaceutical Industry, Haworth Press, Binghamton. NY. Bain, J. S. (1959) Industrial Organization, Wiley, New York. Baird, I. and Kumar, D. (1983) Working Paper University of Illinois, Champaign. Barney, J. and Hoskisson, R. (1990) Managerial and Decision Economics, 11, 187 -198. Boeker, W. (1991) Academy of management Journal, 34, 613-635. Bogner, W. C. (1991) University of Illinois at Urbana Champaign, pp. 513. Carroll, G. R. and Swaminathan, A. (1992) Industrial and Corporate Change, 1, 65-97. Caves, R. and Pugel, T. (1980) Intraindustry differences in conduct and performance viable strategies in US manufacturing firms., New York. Caves, R. E. and Porter, M. E. (1977) Quarterly Journal of Economics, 91, 241 - 261. Cool, K. (1985) Purdue University, pp. 566. Cool, K. and Dierickx, I. (1993) Strategic Management Journal, 14, 47 - 59. Cool, K., Dierickx, I. and Martens, R. (1994) In Strategic Groups, Strategic Moves and Performance(Ed, Daems, H., and Howard Thomas) Pergamon, pp. 219-234. Cool, K. O. and Schendel, D. (1987a). Cool, K. O. and Schendel, D. (1987b) Management Science, 33, 1102-1124. Corstjens, M. (1991) Marketing Strategy in the Pharmaceutical Industry, Chapman & Hall, London. Curto, F. (1998) In Warwick Business SchoolWarwick University, Warwick, pp. 397. Dess, G. and Davis, P. (1984) Academy of Management Journal, 467 - 488. Dranove, D., Peteraf, M. A. and Shanley, M. (1998) Strategic Management Journal, 1029-1044. Fiegenbaum, A. (1987) University of Illinois, Champaign. Fiegenbaum, A. and Primeaux, W. (1985) Working Paper College of Commerce and Business Administration University of Illinois. Fiegenbaum, A., Sudharshan, D. and Thomas, H. (1987) Managerial and Decision Economics, 8, 139148. Fiegenbaum, A. and Thomas, H. (1995) Strategic Management Journal, 16, 461-476. Hannan, M. T. and Freeman, J. (1977) American Journal of Sociology, 82. Hatten, K. (1974) Purdue University. Hawthorne, F. (2003) The Merck Druggernaut: the Inside Story of a Pharmaceutical Giant, John Wiley & Sons, Chichester. Hergert, M. (1983) Harvard University. Hunt, M. S. (1972) Harvard University, Cambridge, MA. Ketchen, D. J. and Shook, C. L. (1996) Strategic Management Journal, 17, 441-458. Martens, R. (1988) In Faculty of Applied EconomicsUFSIA Antwerp University, Antwerp, pp. 402. Mascarenhas, B. (1989) Academy of Management Journal, 32, 333-352. Mascarenhas, B. and Aaker, D. A. (1989) Strategic Management Journal, 10, 475-485. Mason, E. (1949) Harvard Law Review, 62, 1265-1285. McGee, J. (1985) In Strategic Marketing and Management(Eds, Thomas, H. and Gardner, D.) John Wiley & Son, Chichester, pp. 293-314. McGee, J. (2003) In The Oxford Handbook of Strategy: A Strategy Overview and Competitive Strategy, Vol. 1 (Eds, Faulkner, D. O. and Campbell, A.) Oxford University Press, Oxford, pp. 261-301. McGee, J. and Thomas, H. (1986) Strategic Management Journal, 141-160. McNamara, G., Deephouse, D. L. and Luce, R. A. (2003) Strategic Management Journal, 24, 161-181. McNamara, G., Luce, R. A. and Tompson, G. H. (2002) Strategic Management Journal, 23, 153-170. Mehra, A. and Floyd, S. W. (1998) Journal of Management, 24, 511-531. Miles, R. E. and Snow, C. C. (1978) Organizational Strategy, Structure and Process, McGraw Hill. Strategic Group Theory: review, examination and application in the UK pharmaceutical industry. Nair, A. and Filler, L. (2003) Strategic Management Journal, 24, 145-159. Newman, H. (1973) Harvard University. Newman, H. H. (1978) Review of Economics and Statistics, August 1978, 417-427. Oster, S. (1982) Review of Economics and Statistics, LXIV, 376-383. Oster, S. M. (1994) Modern Competitive Analysis, Oxford University Press, New York. Patton, G. (1976) Purdue University. Porac, J. F., Thomas, H. and Baden-Fuller, C. W. F. (1989) Journal of Management Studies, 26, 397416. Porac, J. F., Thomas., H. and Baden-Fuller, C. W. F. (1994) In Strategic Groups, Strategic Moves and Performance(Eds, Daems, H. and Thomas., H.) Elsevier Science Ltd, Oxford, pp. 117-137. Porter, M. E. (1973) Harvard University. Porter, M. E. (1976) Interbrand Choice, Strategy, and Bilateral Market Power, Harvard University Press, Cambridge, Massachusets. Porter, M. E. (1979) Review of Economics and Statistics, 602-613. Porter, M. E. (1980) Competitive Strategy. Techniques for Analyzing Industries and Competitors, Free Press, New York. Prahalad, C. K. and Hamel, G. (1990) Harvard Business Review, 68, 79 - 91. Primeaux, W. J. (1985) In Strategic Marketing and Management(Eds, Thomas, H. and Gardner, D.) John Wiley & Sons, Chichester, pp. 315 - 328. Redwood, H. (1988) The Pharmaceutical Industry: Trends, Problems and Achievements, Oldwicks, Felixstowe. Reger, R. (1988) University of Illinois, Champaign. Ryans, A. and Wittinck, D. (1985) In Strategic Marketing and Management(Eds, Thomas, H. and Gardner, D.) John Wiley & Sons, Chichester, pp. 329 - 346. Taggart, J. (1993) The World Pharmaceutical Industry, Routledge, New York. Warren, K. (2002) Competitive Strategy Dynamics, John Wiley & Sons, Chichester. Zuniga-Vicente, J. A., Fuente-Sabate, J. M. d. l. and Rodriguez-Puerta, J. (2004) British Journal of Management, 15, 219-245. 2